Pharmaceutical
The EU Pharma Package and Critical Medicines Act: What Global Companies Need to Know in 2026
The European Union's new General Pharmaceutical Legislation and the Critical Medicines Act have been finalized, representing the most significant overhaul of European medicines law in over two decades. Here is what global companies must know to adapt.
Biotechnology
The European Biotech Act 2026: A Catalyst for Competitiveness and Innovation in Health Biotechnology
The European Commission has proposed the European Biotech Act to turbocharge the EU's health biotechnology sector, streamline regulations, and regain global competitiveness against the US and China.
Pharmaceutical
Avectas: Engineering the Future of Cell Therapy Manufacturing
Recognizing the critical industry bottleneck in scalable cell therapy production, Avectas has announced a landmark collaboration with CCRM and OmniaBio to evaluate its innovative manufacturing platform.
Clinical Trials
Navigating Challenges in Oncology: Jazz Pharmaceuticals and PharmaMar Stay Committed Despite Phase 3 Setback
In the rigorous and highly demanding landscape of oncology research, scientific progress is often non-linear. Recently, Jazz Pharmaceuticals and its partner PharmaMar announced that their Phase 3 trial evaluating Zepzelca did not meet its primary endpoint.
LinkedIn
How to Create a LinkedIn Profile Using AI: The 2026 Guide for Life Science Professionals
Step-by-step guide to building a standout LinkedIn profile using ChatGPT and AI tools - written for pharma, biotech, and MedTech professionals in Ireland. Includes copy-paste AI prompts for every section.
Regulatory Affairs
Landmark Agreements on Medicine Pricing and Supply Target 180-Day Turnaround by 2029
The Irish government signs major new Framework Agreements with MFI and IPHA, aiming to reduce patient wait times for innovative treatments to 180 days by 2029.
Pharmaceutical
The Weight-Loss Drug Boom: Novo Nordisk's €432 Million Athlone Expansion
Novo Nordisk commits €432 million to upgrade its Athlone facility, expanding manufacturing capacity for oral GLP-1 weight-loss and diabetes treatments.
Biotechnology
Rare Disease Bottlenecks vs. Encouraging Clinical Trial Growth in Ireland
Despite encouraging growth in clinical trial activity, patients in Ireland face an average wait of 801 days for access to rare disease medicines, prompting calls for urgent systemic reform.
MedTech
Medtronic Completes $550M Acquisition of Scientia Vascular to Advance Neurovascular Care
Galway-headquartered Medtronic has completed its $550 million acquisition of Scientia Vascular, integrating best-in-class guidewires and catheters into its neurovascular portfolio to transform stroke treatment globally.
Industry
Prime Minister Carney Expands Canada-Ireland Partnership in Science, Technology, and Pharma
Canadian Prime Minister Mark Carney's landmark visit to Ireland strengthens bilateral cooperation in artificial intelligence, biomanufacturing, and resilient health systems, highlighting massive new investments in the life science sector.
Industry
Europe's United Front: How the Beneluxa Initiative is Defending the Pharma Framework Against US Pricing Pressure
With the US pushing for individual drug pricing deals and Germany slashing healthcare spending, the Beneluxa Initiative represents five European nations calling for a unified, coordinated approach to protect Europe's pharmaceutical innovation and access to medicines in 2026.
Industry
Fueling Prosperity: How Ireland is Leveraging its Economic Boom for Future Generations
A positive look at the June 2026 Fiscal Assessment Report, highlighting Ireland's strategic investments, robust corporate tax windfalls, and bold plans for infrastructure and savings funds.